EASYPUMP II LT 270-27-S
Report
- Report Number
- 3009089744-2013-00005
- Event Type
- Malfunction
- Date Received
- January 31, 2013
- Date of Event
- January 10, 2013
- Report Date
- January 31, 2013
- Manufacturer
- B. BRAUN MEDICAL PRODUCTION LTD.
- Product Code
- MEB
- PMA / PMN Number
- K081905
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- FR
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
Narratives
THIS REPORT HAS BEEN IDENTIFIED AS B. BRAUN (B)(4). WE RECEIVED ONE USED QUARTER-FILLED (CONTAMINATED WITH CYTOSTATIC AGENT), EASYPUMP II LT (B)(4) WITHOUT PASSAGE. THE RECEIVED SAMPLE WAS TAKEN TO A VISUAL EXAMINATION. DAMAGES WERE NOT DETECTED AT THE SAMPLE. IN AS-RECEIVED CONDITION THE WHITE CLAMP WAS CLOSED AND THE LOSING CONE AT THE TOP CAP WAS MISSING. AFTER OPENING THE TOP CAP, WE DETECTED NO CRYSTALLIZED DRUG RESIDUES AT THE FILLING PORT (LLI-CONE). MOREOVER WE DETECTED NO AIR INSIDE THE TUBE HOWEVER ONE AIR BUBBLE WAS DETECTED INSIDE THE FLOW RESTRICTOR. IN ADDITION WE DETECTED RESIDUES OF FLUID INSIDE THE LLA-CONE OF THE PT CONNECTOR. AFTERWARDS THE SAMPLE WAS TAKEN TO A FUNCTIONAL TEST RESPECTIVELY TO A LEAK TEST. AFTER OPENING THE WHITE CLAMP AND WAITING FOR A WHILE, THE PUMP WORKED (SOLUTION WAS RUNNING). LEAKAGES WERE NOT DETECTED. FURTHERMORE THE FLOW RATE WAS TESTED. NOMINAL: 10 ML/H. ACTUAL: 9.8 ML IN 1 H; 19.4 ML IN 2 H; 29.2 ML IN 3 H. THE RECEIVED SAMPLE IS WITHIN OUR REQUIREMENTS. NEVERTHELESS WE HAVE INFORMED OUR PRODUCTION SITE ACCORDINGLY. A FOLLOW-UP REPORT WILL BE PROVIDED AFTER THE STATEMENT OF THE PRODUCTION SITE IS AVAILABLE.
AS REPORTED BY THE USER FACILITY (TRANSLATION OF USER FACILITY INFO BY BBM SALES ORGANIZATION IN (B)(6)): STOP OF THE INFUSION. DRUG: TAZOCILLINE 8G.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 43023 | EASYPUMP II LT 270-27-S | ELASTOMERIC INFUSION PUMP | MEB | B. BRAUN MEDICAL PRODUCTION LTD. | NA | 1M0128ED12 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | UNK | Other |